Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pharmacology of the Endothelium in Ischemia-Reperfusion and Circulatory Shock

Pharmacology of the Endothelium in Ischemia-Reperfusion and Circulatory Shock Allan M. Le fer Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 David J. Le fer Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224 KEY WORDS: nitric oxide, endothelial dysfunction, adhesion molecules, ischemia-reperfu­ sion, neutrophils BASIC PHYSIOLOGY OF HUMORAL AGENTS OF ENDOTHELIAL ORIGIN During the past years, great strides have been made in elucidating the regulatory role of the endothelium in vascular dynamics. The endothelium was previously thought of only as a permeability barrier to ions and organic molecules, and as a regional site of metabolic effects, particularly in the pUlmonary microvasculature (i.e. converting angiotensin I to angiotensin II and removing prostaglandins from the circulation) (1). Although these effects are of considerable significance, they did not foretell the far-reaching role of the entire vascular endothelium as an important organ in regulating vascular tone. Cytoprotective Agents Produced by the Endothelium In 1976, Vane, Moncada, and colleagues (2) discovered PGh (prostacyclin), a unique eicosanoid produced by the endothelium. PGh exerts a remarkable constellation of actions, including vasodilation of most vasculatures, inhi- 0362-1642/93/0415-0071$02.00 LEFER & LEFER bition of platelet aggregation, prevention of polymorphonuclear (PMN) leukocyte adherence, and stabilization of membranes (3-5). Prostacyclin has http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annual Review of Pharmacology and Toxicology Annual Reviews

Pharmacology of the Endothelium in Ischemia-Reperfusion and Circulatory Shock

Loading next page...
 
/lp/annual-reviews/pharmacology-of-the-endothelium-in-ischemia-reperfusion-and-Ehmetn4hjK

References (45)

Publisher
Annual Reviews
Copyright
Copyright 1993 Annual Reviews. All rights reserved
Subject
Review Articles
ISSN
0362-1642
eISSN
1545-4304
DOI
10.1146/annurev.pa.33.040193.000443
pmid
8494355
Publisher site
See Article on Publisher Site

Abstract

Allan M. Le fer Department of Physiology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 David J. Le fer Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224 KEY WORDS: nitric oxide, endothelial dysfunction, adhesion molecules, ischemia-reperfu­ sion, neutrophils BASIC PHYSIOLOGY OF HUMORAL AGENTS OF ENDOTHELIAL ORIGIN During the past years, great strides have been made in elucidating the regulatory role of the endothelium in vascular dynamics. The endothelium was previously thought of only as a permeability barrier to ions and organic molecules, and as a regional site of metabolic effects, particularly in the pUlmonary microvasculature (i.e. converting angiotensin I to angiotensin II and removing prostaglandins from the circulation) (1). Although these effects are of considerable significance, they did not foretell the far-reaching role of the entire vascular endothelium as an important organ in regulating vascular tone. Cytoprotective Agents Produced by the Endothelium In 1976, Vane, Moncada, and colleagues (2) discovered PGh (prostacyclin), a unique eicosanoid produced by the endothelium. PGh exerts a remarkable constellation of actions, including vasodilation of most vasculatures, inhi- 0362-1642/93/0415-0071$02.00 LEFER & LEFER bition of platelet aggregation, prevention of polymorphonuclear (PMN) leukocyte adherence, and stabilization of membranes (3-5). Prostacyclin has

Journal

Annual Review of Pharmacology and ToxicologyAnnual Reviews

Published: Apr 1, 1993

There are no references for this article.